Biomea Fusion, Inc. (BMEA)
0.5668
-0.02
(-3.51%)
USD |
NASDAQ |
Nov 06, 16:00
0.5679
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.128M |
| September 30, 2025 | 6.089M |
| June 30, 2025 | 6.299M |
| March 31, 2025 | 6.501M |
| December 31, 2024 | 6.692M |
| September 30, 2024 | 6.875M |
| June 30, 2024 | 7.053M |
| March 31, 2024 | 7.926M |
| December 31, 2023 | 7.83M |
| September 30, 2023 | 9.265M |
| June 30, 2023 | 10.01M |
| Date | Value |
|---|---|
| March 31, 2023 | 10.74M |
| December 31, 2022 | 1.667M |
| September 30, 2022 | 1.826M |
| June 30, 2022 | 1.984M |
| March 31, 2022 | 2.137M |
| December 31, 2021 | 2.285M |
| September 30, 2021 | 2.431M |
| June 30, 2021 | 2.575M |
| March 31, 2021 | 55.74M |
| December 31, 2020 | 55.74M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| REGENXBIO, Inc. | 245.73M |
| Compass Therapeutics, Inc. | 7.996M |
| ACADIA Pharmaceuticals, Inc. | 57.32M |
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Anika Therapeutics, Inc. | 24.56M |